Description
Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used for the treatment of breast cancer.
The most common adverse reactions include diarrhea, cutaneous adverse reactions, increased random glucose, decreased lymphocytes, decreased hemoglobin, increased fasting glucose, nausea, fatigue, decreased leukocytes, increased triglycerides, decreased neutrophils, increased creatinine, vomiting, and stomatitis.
In November 2023, capivasertib was approved in the United States for people with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer when used in combination with fulvestrant. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Capivasertib is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “TRUQAP (capivasertib) tablets in India“, patients can simply fill the order form or, please call us at 9811747774, 9555306364 or WhatsApp at 9555306364, 9555306364 or email us at info@lucknowpharma.com. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
NEWS / UPDATES





